Shares of OpGen, Inc. (NASDAQ:OPGN – Get Free Report) crossed below its 50-day moving average during trading on Friday . The stock has a 50-day moving average of $1.33 and traded as low as $0.59. OpGen shares last traded at $0.75, with a volume of 22,117 shares trading hands.
Wall Street Analysts Forecast Growth
Separately, StockNews.com initiated coverage on shares of OpGen in a research report on Saturday. They issued a “sell” rating for the company.
Check Out Our Latest Stock Report on OpGen
OpGen Trading Up 42.3 %
About OpGen
OpGen, Inc, a precision medicine company, engages in developing and commercializing molecular microbiology solutions in the United States and internationally. Its product portfolio includes Acuitas AMR Gene Panel, an in vitro diagnostic (IVD) test for the detection and identification of various bacterial nucleic acids and genetic determinants of antimicrobial resistance (AMR) from bacterial colonies isolated from any specimen, as well as Curetis CE-IVD-marked polymerase chain reaction-based SARS-CoV-2 test kits.
See Also
- Five stocks we like better than OpGen
- What Are the U.K. Market Holidays? How to Invest and Trade
- Insiders Are Selling, But These 3 Stocks Are Must-Buys
- Which Wall Street Analysts are the Most Accurate?
- Rivian Defies Doubters: Delivery Triumph Fuels Stock Surge
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Hindenburg Short Report Slams Carvana Over Alleged ‘Grift’
Receive News & Ratings for OpGen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OpGen and related companies with MarketBeat.com's FREE daily email newsletter.
